Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Heilig

Showing results (91-100 of 313) with videos related to

Pageof 32
Sort By:
Psychopharmacology|January 30, 2010
Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in miceAnnika Thorsell, Jesse R Schank, Erick Singley, et al.
Physiology & Behavior|December 10, 2017
A cannabinoid receptor antagonist attenuates ghrelin-induced activation of the mesolimbic dopamine system in miceAimilia Lydia Kalafateli, Daniel Vallöf, Julia Winsa Jörnulf, et al.
Neuroimage. Clinical|June 30, 2020
Sharpened self-other distinction in attention deficit hyperactivity disorderRebecca Boehme, Morgan Frost Karlsson, Markus Heilig, et al.
The European Journal of Neuroscience|April 17, 2008
Neuroplasticity in brain reward circuitry following a history of ethanol dependenceAnita C Hansson, Roberto Rimondini, Olga Neznanova, et al.
Neuron|October 9, 2012
Stress-related neuropeptides and addictive behaviors: beyond the usual suspectsJesse R Schank, Andrey E Ryabinin, William J Giardino, et al.
Alcoholism, Clinical and Experimental Research|February 27, 2003
Neuropeptide y and alcoholism: genetic, molecular, and pharmacological evidenceSubhash C Pandey, Lucinda G Carr, Markus Heilig, et al.
Addiction Biology|January 21, 2012
Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusersSharon L Walsh, Markus Heilig, Paul A Nuzzo, et al.
Addiction Biology|May 12, 2010
Ethanol-induced activation of AKT and DARPP-32 in the mouse striatum mediated by opioid receptorsKarl Björk, Anton Terasmaa, Hui Sun, et al.
Addiction Biology|February 23, 2017
Addiction research and theory: a commentary on the Surgeon General's Report on alcohol, drugs, and healthAldo Badiani, Kent C Berridge, Markus Heilig, et al.
Neuromodulation : Journal of the International Neuromodulation Society|October 30, 2018
Lack of Target Engagement Following Low-Frequency Deep Transcranial Magnetic Stimulation of the Anterior InsulaPrimavera A Spagnolo, Han Wang, Prachaya Srivanitchapoom, et al.
Pageof 32

Showing results (91-100 of 313) with videos related to

Sort By:
Pageof 32
Psychopharmacology|January 30, 2010
Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in miceAnnika Thorsell, Jesse R Schank, Erick Singley, et al.
Physiology & Behavior|December 10, 2017
A cannabinoid receptor antagonist attenuates ghrelin-induced activation of the mesolimbic dopamine system in miceAimilia Lydia Kalafateli, Daniel Vallöf, Julia Winsa Jörnulf, et al.
Neuroimage. Clinical|June 30, 2020
Sharpened self-other distinction in attention deficit hyperactivity disorderRebecca Boehme, Morgan Frost Karlsson, Markus Heilig, et al.
The European Journal of Neuroscience|April 17, 2008
Neuroplasticity in brain reward circuitry following a history of ethanol dependenceAnita C Hansson, Roberto Rimondini, Olga Neznanova, et al.
Neuron|October 9, 2012
Stress-related neuropeptides and addictive behaviors: beyond the usual suspectsJesse R Schank, Andrey E Ryabinin, William J Giardino, et al.
Alcoholism, Clinical and Experimental Research|February 27, 2003
Neuropeptide y and alcoholism: genetic, molecular, and pharmacological evidenceSubhash C Pandey, Lucinda G Carr, Markus Heilig, et al.
Addiction Biology|January 21, 2012
Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusersSharon L Walsh, Markus Heilig, Paul A Nuzzo, et al.
Addiction Biology|May 12, 2010
Ethanol-induced activation of AKT and DARPP-32 in the mouse striatum mediated by opioid receptorsKarl Björk, Anton Terasmaa, Hui Sun, et al.
Addiction Biology|February 23, 2017
Addiction research and theory: a commentary on the Surgeon General's Report on alcohol, drugs, and healthAldo Badiani, Kent C Berridge, Markus Heilig, et al.
Neuromodulation : Journal of the International Neuromodulation Society|October 30, 2018
Lack of Target Engagement Following Low-Frequency Deep Transcranial Magnetic Stimulation of the Anterior InsulaPrimavera A Spagnolo, Han Wang, Prachaya Srivanitchapoom, et al.
Pageof 32